Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05366699 · ClinicalTrials.gov registry record · NA
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
A NA study of Lymphedema and Lymphedema, Breast Cancer, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05366699: Recruiting NA study of Lymphedema and Lymphedema, Breast Cancer, sponsored by Stanford University.
NCT05366699 is a NA study of Lymphedema and Lymphedema, Breast Cancer that is actively recruiting participants, run by Stanford University. The registered enrollment target is 80 participants, below the 9,297-participant average among 34 other Lymphedema trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05366699, a NA study of Lymphedema and Lymphedema, Breast Cancer, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Lymphedema is a chronic, progressive, and debilitating condition that occurs with disruption or obstruction of the lymphatic system, which commonly occurs a result of breast cancer therapy. The purpose of this study is to determine if the use of a low risk lymphatic reconstruction procedure at the time of axillary lymph node dissection will reduce the risk of developing lymphedema. Additionally, to determine if this procedure improves objective outcomes of lymphedema and patient quality of life
Primary Outcome
In the early lymphedema stages this exam allows to detect percutaneously the lymphatic vessels of the whole limb, up to about 1 cm in depth from the skin surface, by an infrared camera visualization system after intra-dermal injection of ICG in the hand. The change in the lymphatic pattern and reduction in the ICG velocity will be tested to find a correlation with other used diagnostic parameters like volume change and bioimpedance spectroscopy.
Conditions Studied
Interventions
- PROCEDURE axillary lymphadenectomy with immediate lymphatic reconstruction (LYMPHA)
- PROCEDURE Axillary lymphadenetomy alone
- PROCEDURE axillary lymphadenectomy with soft tissue reinforcement
Study Locations (1)
California
- Stanford Cancer Institute - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-09-10 |
| Est. Completion | 2030-06-01 |
| Phase | NA |
What NCT05366699 shows while recruiting
NCT05366699 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 9,297-participant average among 34 other Lymphedema trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Lymphedema appearing as the primary indexed condition, and to 3 interventions - of which axillary lymphadenectomy with immediate lymphatic reconstruction (LYMPHA) is the first listed.
NCT05366699 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05366699 about?
NCT05366699 is a clinical study titled "LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy". Lymphedema is a chronic, progressive, and debilitating condition that occurs with disruption or obstruction of the lymphatic system, which commonly occurs a result of breast cancer therapy. The purpose of this study is to determine if the use of a low risk lymphatic reconstruction procedure at the t...
What is the current status of trial NCT05366699?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2021-09-10. Estimated completion is 2030-06-01.
What conditions does trial NCT05366699 study?
This clinical trial studies the following conditions: Lymphedema, Lymphedema, Breast Cancer.
What interventions are being tested in trial NCT05366699?
The interventions under investigation include: axillary lymphadenectomy with immediate lymphatic reconstruction (LYMPHA) (PROCEDURE), Axillary lymphadenetomy alone (PROCEDURE), axillary lymphadenectomy with soft tissue reinforcement (PROCEDURE).
Who is sponsoring clinical trial NCT05366699?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05366699 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphedema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05366699's enrollment target sits among peer trials
80 20th of 34 higher than 14 of 34 other Lymphedema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lymphedema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
RECRUITING · NA
-
Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema
RECRUITING · NA
-
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
RECRUITING · NA
-
Pedal Pump and Leg Lymphedema
RECRUITING · NA
-
Comparing Two Ways to Manage Head and Neck Lymphedema
RECRUITING · NA
-
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI